Vertex Pharmaceuticals (VRTX) - 27 Year Stock Price History

Historical daily stock prices for Vertex Pharmaceuticals since 1991 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Vertex Pharmaceuticals (VRTX) as of June 20, 2018 is 157.63.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $40.169B $2.489B
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.